Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telaprevir for HCV Post-Exposure Prophylaxis in Health Care Workers
NCT01766115Phase 4Withdrawn
- Sponsor
- Massachusetts General Hospital
- Start
- Apr 2013
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of telaprevir in hepatitis C (HCV), sponsored by Massachusetts General Hospital. Planned start Apr 2013; status: withdrawn.
02
Drugs
telaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01766115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01766115.